Combination of Quinupristin-Dalfopristin (Synercid) and Rifampin Is Highly Synergistic in Experimental Staphylococcus aureus Joint Prosthesis Infection

We compared the efficacies of quinupristin-dalfopristin (Q-D; 30 mg/kg of body weight every 8 h) and vancomycin (60 mg/kg twice daily), alone or in combination with rifampin (10 mg/kg twice daily), in a rabbit model of methicillin-resistant Staphylococcus aureus knee prosthesis infection. In contras...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Saleh-Mghir, Azzam, Ameur, Nourdine, Muller-Serieys, Claudette, Ismael, Farid, Lemaitre, Françoise, Massias, Laurent, Feger, Céline, Bléton, Rémy, Crémieux, Anne-Claude
Формат: Artigo
Язык:Inglês
Опубликовано: American Society for Microbiology 2002
Предметы:
Experimental Therapeutics
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC127098/
https://ncbi.nlm.nih.gov/pubmed/11897604
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.46.4.1122-1124.2002
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы